Stealth BioTherapeutics (MITO) Tops Q3 EPS by 1c; Reports Cash and Cash Equivalents of $42.3M
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
Tweet
Share
E-mailGet Alerts MITO Hot Sheet
Join SI Premium – FREE
Stealth BioTherapeutics (NASDAQ: MITO) reported Q3 EPS of ($0.01), $0.01 better than the analyst estimate of ($0.02).
For earnings history and earnings-related data on Stealth BioTherapeutics (MITO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Becton Dickinson (BDX) Tops Q4 EPS by 8c; Offers Guidance
- Wendy's (WEN) Tops Q3 EPS by 3c
- Tecnoglass (TGLS) Tops Q3 EPS by 2c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
